Form 4 for GALT GALECTIN THERAPEUTICS INC
Accepted 2024-04-25 00:00:00 ET · period of report 2024-04-24 · accession 0001133416-24-000040 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-04-25 | 2024-04-24 | GALT | LEWIS JOEL | Pres, CEO, Dir | P - Purchase | $3.39 | +1,000 | 2,000 | +100% | +$3,390 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-24 | P | A | 1,000 | $3.39 | 2,000 | I as UTMA custodian for a minor child | — | — | (F1) Represents average price in multiple transactions with low of $3.30 per share and high of $3.41 per share (F2) These shares are held of record by the Reporting Person as custodian for a minor child under the Uniform Transfer to Minors Act. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purpose of Section 16 or for any other purpose. |